Keynote Presentation: Moving Precision Medicine from 'Exotic' to 'Normal'

Pharmacogenomics has had rapid implementation over the past decade, with recent growth in application in oncology, mental health, solid organ transplantation, and more. There has been much focus on specific drug-gene-action relationships, such that there are now a number of actionable pharmacogenomics examples. With the application of panel testing, there are often additional opportunities to impact a patient’s care, beyond the specific disease focus area.  This shift from the gene/drug pairing to the broader look across the patient’s current and future needs is an inflection point in moving pharmacogenomics into routine usage.

Learning Objectives:

1. Define the impact of pharmacogenomics on a patient’s risk:benefit decision

2. Identify various challenges in implementing pharmacogenomics from research to practice

3. Explain current approaches to applying pharmacogenomics panel testing in the clinic